title: Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.
authors.forename: J C
authors.initials: JC
authors.lastname: Kahn
authors.forename: M
authors.initials: M
authors.lastname: Patey
authors.forename: J L
authors.initials: JL
authors.lastname: Dubois-Rande
authors.forename: P
authors.initials: P
authors.lastname: Merlet
authors.forename: A
authors.initials: A
authors.lastname: Castaigne
authors.forename: C
authors.initials: C
authors.lastname: Lim-Alexandre
authors.forename: J M
authors.initials: JM
authors.lastname: Lecomte
authors.forename: D
authors.initials: D
authors.lastname: Duboc
authors.forename: C
authors.initials: C
authors.lastname: Gros
authors.forename: J C
authors.initials: JC
authors.lastname: Schwartz
mesh_terms: D000284:Administration, Oral; D009320:Atrial Natriuretic Factor / Q000097:blood*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015260:Neprilysin / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D015244:Thiorphan / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: C049331:racecadotril; D009320:Atrial Natriuretic Factor; D015244:Thiorphan; D015260:Neprilysin